Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats

European Journal of Pharmacology

Volumn 532, Issue 3, 2006, Pages 236-245

  Kitaichi, Yuji ^a   Inoue, Takeshi ^a   Nakagawa, Shin ^a   Izumi, Takeshi ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Clorgyline; Conditioned fear stress; In vivo microdialysis; Li2CO3; Noradrenaline; Serotonin

Indexed keywords

CLORGYLINE; DOPAMINE; LAZABEMIDE; LITHIUM CARBONATE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; NORADRENALIN; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONDITIONING; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG EFFECT; FACILITATION; FEAR; IMMOBILIZATION; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN BRAIN LEVEL; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; CLORGYLINE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEAR; LITHIUM CARBONATE; MALE; MODELS, ANIMAL; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NOREPINEPHRINE; PICOLINIC ACIDS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN;

EID: 33644533817     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.078     Document Type: Article

References (44)

1. M. Bauer, and S. Döpfmer Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies J. Clin. Psychopharmacol. 19 1999 427 434
2. U. Berggren The effect of acute lithium administration on brain monoamine synthesis and the precursor amino acids tyrosine and tryptophan in brain and plasma in rats J. Neural Transm. 61 1985 175 181
3. P. Blier, and C. De Montigny Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS Eur. J. Pharmacol. 113 1985 69 77
4. S.P. Butcher, I.S. Fairbrother, J.S. Kelly, and G.W. Arbuthnott Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum J. Neurochem. 55 1990 981 988
5. P. Celada, and F. Artigas Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei Naunyn-Schmiedeberg's Arch. Pharmacol. 347 1993 583 590
6. A. Colzi, F. d'Agostini, R. Kettler, E. Borroni, and M. Da Plada Effect of selective and reversible MAO inhibitors on dopamine outflow in rat striatum: a microdialysis study J. Neural Transm., Suppl. 32 1990 79 84
7. O. Curet, G. Damoiseau-Ovens, C. Sauvage, N. Sontag, P. Avenet, H. Depoortere, D. Caille, O. Bergis, and B. Scatton Preclinical profile of befloxatone, a new reversible MAO-A inhibitor J. Affect. Disord. 51 1998 287 303
8. M. Da Prada, R. Kettler, H.H. Keller, W.P. Burkard, D. Muggli-Maniglio, and W.E. Haefely Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A J. Pharmacol. Exp. Ther. 248 1989 400 414
9. M. Da Prada, R. Kettler, H.H. Keller, A.M. Casura, J.G. Richards, J. Marti, D. Muggli-Maniglio, P.C. Wyss, E. Kyburz, and R. Imhof From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors J. Neural Transm., Suppl. 29 1990 279 292
10. L. Eroglu, and A. Hizal Antidepressant action of lithium in behavioral despair test Pol. J. Pharmacol. Pharm. 39 1987 667 673
11. M.S. Fanselow Conditioned and unconditional components of post shock freezing Pavlovian J. Biol. Sci. 15 1980 177 182
12. M.S. Fanselow, and F.J. Helmstetter Conditional analgesia, defensive freezing, and benzodiazepines Behav. Neurosci. 102 1988 233 243
13. S. Fein, V. Paz, N. Rao, and J. LaGrassa The combination of lithium carbonate and MAOI in refractory depressions Am. J. Psychiatry 145 1988 249 250
14. J.P.M. Finberg, K. Pacak, I.J. Kopin, and D.S. Goldstein Chronic inhibition of monoamine oxidase type A increases noradrenaline release in rat frontal cortex Naunyn-Schmiedeberg's Arch. Pharmacol. 347 1993 500 505
15. J.B. Frank, T.R. Kosten, E.L. Giller Jr., and E. Dan A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder Am. J. Psychiatry 145 1988 1289 1291
16. D. Ghoshdastidar, and M.K. Poddar Long term effect of lithium on brain regional catecholamine metabolism Indian J. Exp. Biol. 28 1990 444 450
17. D.G. Grahame-Smith, and A.R. Green The role of brain 5-hydroxytryptamine in the hyperactivity produced in rats by lithium and monoamine oxidase inhibitors Br. J. Pharmacol. 52 1974 19 26
18. A.R. Green, and D.W. Costain Pharmacology and Biochemistry of Psychiatric Disorders 1981 Wiley Chichester
19. S. Hashimoto, T. Inoue, and T. Koyama Serotonin reuptake inhibitors reduce conditioned fear stress-induced freezing behavior in rats Psychopharmacology 123 1996 182 186
20. S. Hashimoto, T. Inoue, and T. Koyama The effects of the co-administration of 5-HT1A receptor antagonists with an SSRI in conditioned fear stress-induced freezing behavior Pharmacol. Biochem. Behav. 58 1997 471 475
21. T. Inoue, K. Tsuchiya, and T. Koyama Serotonergic activation reduces defensive freezing in the conditioned fear paradigm Pharmacol. Biochem. Behav. 53 1996 825 831
22. P.G. Janicak, J.M. Davis, and S.H. Preskorn Principles and Practice of Psychopharmacotherapy 3rd ed. 2001 Lippincott Williams and Wilkins Philadelphia
23. Y. Kitaichi, T. Inoue, S. Nakagawa, T. Izumi, and T. Koyama Effect of co-administration of lithium and reboxetine on extracellular monoamine concentrations in rats Eur. J. Pharmacol. 489 2004 187 191
24. Y. Kitaichi, T. Inoue, S. Nakagawa, T. Izumi, and T. Koyama Effect of milnacipran on extracellular monoamine concentrations in the medial prefrontal cortex of rats pre-treated with lithium Eur. J. Pharmacol. 516 2005 219 226
25. I. Lamensdorf, M.B. Youdim, and J.P. Finberg Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo J. Neurochem. 67 1996 1532 1539
26. M.R. Liebowitz, F. Schneier, R. Campeas, E. Hollander, J. Hatterer, A. Fyer, J. Gorman, L. Papp, S. Davies, R. Gully, and D.F. Klein Phenelzine vs. atenolol in social phobia. A placebo-controlled comparison Arch. Gen. Psychiatry 49 1992 290 300
27. Y. Maki, T. Inoue, T. Izumi, I. Muraki, K. Ito, Y. Kitaichi, X. Li, and T. Koyama Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats Eur. J. Pharmacol. 406 2000 411 418
28. I. Muraki, T. Inoue, S. Hashimoto, T. Izumi, K. Ito, T. Ohmori, and T. Koyama Effect of subchronic lithium carbonate treatment on anxiolytic-like effect of citalopram and MKC-242 in conditioned fear stress in the rat Eur. J. Pharmacol. 383 1999 223 229
29. I. Muraki, T. Inoue, S. Hashimoto, T. Izumi, K. Ito, and T. Koyama Effect of subchronic lithium treatment on citalopram-induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex J. Neurochem. 76 2001 490 497
30. J.C. Nelson, and R. Byck Rapid response to lithium in phenelzine non-responders Br. J. Psychiatry 141 1982 85 86
31. Y. Odagaki, T. Koyama, and I. Yamashita Lithium and serotonergic neural transmission: a review of pharmacological and biochemical aspects in animal studies Lithium 3 1992 95 107
32. T. Ohmori, T. Abekawa, A. Muraki, and T. Koyama Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine Pharmacol. Biochem. Behav. 48 1994 587 591
33. J. Perez-Cruet, A. Tagliamonte, P. Tagliamonte, and G.L. Gess Stimulation of serotonin synthesis by lithium J. Pharmacol. Exp. Ther. 178 1971 325 330
34. L.H. Price, and G.R. Heninger Lithium in the treatment of mood disorders N. Engl. J. Med. 331 1994 591 598
35. P.A. Rittenhouse, E.A. Bakkum, P.A. O'Connor, M. Carnes, C.L. Bethea, and L.D. van de Kar Comparison of neuroendocrine and behavioral effects of ipsapirone, a 5-HT1A agonist, in three stress paradigms: immobilization, forced swim and conditioned fear Brain Res. 580 1992 205 214
36. F.R. Schneier, D. Goetz, R. Campeas, B. Fallon, R. Marshall, and M.R. Liebowitz Placebo-controlled trial of moclobemide in social phobia Br. J. Psychiatry 172 1998 70 77
37. M.H. Sheard, and G.K. Aghajanian Neuronally activated metabolism of brain serotonin: effect of lithium Life Sci. 9 1970 285 290
38. D.V. Sheehan, J. Ballenger, and G. Jacobsen Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms Arch. Gen. Psychiatry 37 1980 51 59
39. G. Stein, and M. Bernadt Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses Br. J. Psychiatry 162 1993 634 640
40. M.E. Thase, and A.J. Rush Treatment-resistant depressions F.E. Bloom D.J. Kupfer Psychopharmacology: The Fourth Generation of Progress 1995 Raven Press New York 1081 1097
41. K. Thomsen, and O.V. Olesen Long-term lithium administration to rats. Lithium and sodium dosage and administration, avoidance of intoxication, polyuric control rats Int. Pharmacopsychiatry 9 1974 118 124
42. I.M. Van Vliet, H.G.M. Westenberg, and J.A. Den Boer MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study Psychopharmacology 112 1993 483 489
43. M. Versiani, A.E. Nardi, F.D. Mundim, A.B. Alves, M.R. Liebowitz, and R. Amrein Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine Br. J. Psychiatry 161 1992 353 360
44. G. Wegener, K. Linnet, R. Rosenberg, and A. Mørk The effect of acute citalopram on extracellular 5-HT levels is not augmented by lithium: an in vivo microdialysis study Brain Res. 871 2000 338 342